C1QA

C1QA encodes the A chain of complement component C1q, the pattern-recognition molecule that initiates the classical complement pathway, functioning in innate immunity, synaptic pruning, and tissue homeostasis. Serum C1q is produced primarily by monocyte-macrophage lineage cells, while brain C1q derives exclusively from microglia; the cationic region (residues 14–26) of C1qA mediates electrostatic binding to immunoglobulin-independent activators, and the globular head domain engages IgG as well as viral proteins such as influenza M1 (PMID:10209207, PMID:11564823, PMID:28264694, PMID:19656971). C1q-initiated classical pathway activation is required for antiviral defense, complement-dependent cytotoxicity of tumor cells, microglial synaptic pruning during development and neurodegeneration, and modulation of neuroinflammatory injury, with C1qa knockout in mice conferring context-dependent protection or exacerbation of pathology in glaucoma, intracerebral hemorrhage, and Alzheimer's disease models (PMID:26544197, PMID:34056877, PMID:39370487, PMID:38266812). C1QA mRNA is post-transcriptionally regulated by METTL3-mediated m6A methylation read by YTHDF2, and intracellularly C1qA enhances RIG-I/MAVS-dependent interferon-β signaling independently of extracellular complement activation (PMID:37907575, PMID:22260551).

1. 1999 High

   Identifying how C1q recognizes immunoglobulin-independent activators resolved a long-standing gap in understanding non-antibody-mediated classical pathway initiation: the cationic segment at residues 14–26 of C1qA mediates electrostatic binding to anionic surfaces.

   Evidence Saturation binding assays with purified C1q and anionic liposomes; charge-dependent peptide inhibition of complement hemolysis

   PMID:10209207

   Open questions at the time

   • Whether this cationic region is sufficient for activator discrimination in vivo
   • No structural data on peptide–liposome interaction at atomic resolution
2. 2001 High

   The cellular origin of circulating C1q was definitively established: bone marrow-derived monocyte-macrophage lineage cells are the primary source, resolving uncertainty about hepatocyte versus myeloid contributions.

   Evidence Reciprocal bone marrow transplantation in C1qa-knockout mice with serum C1q antigen and functional assays

   PMID:11564823

   Open questions at the time

   • Relative contribution of tissue-resident versus circulating macrophages not dissected
   • No mechanism for transcriptional regulation of C1qa in myeloid cells
3. 2009 High

   Demonstration that influenza A M1 protein directly binds the C1qA globular domain to block IgG interaction established a viral immune-evasion mechanism targeting the recognition step of the classical pathway.

   Evidence Co-immunoprecipitation with domain-mapping deletions; hemolysis inhibition in vitro; enhanced viral propagation in mouse lungs

   PMID:19656971

   Open questions at the time

   • Structural basis of M1–C1qA interaction unresolved
   • Generalizability to other viral matrix proteins unknown
4. 2012 Medium

   An unexpected intracellular role for C1qA emerged: it physically interacts with RIG-I and MAVS and enhances type I interferon signaling, placing C1qA in cytoplasmic antiviral innate immunity independently of extracellular complement.

   Evidence Co-immunoprecipitation of C1qA with RIG-I pathway components; ISRE, NF-κB, and IFN-β reporter assays with overexpression and epistasis with gC1qR

   PMID:22260551

   Open questions at the time

   • Endogenous intracellular C1qA levels in relevant cell types not quantified
   • No loss-of-function validation of RIG-I enhancement
   • Single-lab finding not independently confirmed
5. 2015 High

   C1qa was shown to be required for complement-mediated retinal ganglion cell loss in glaucoma, establishing the classical pathway as a driver of neurodegeneration in the eye.

   Evidence C1qa congenic knockout in DBA/2NNia glaucoma mice; retrograde RGC labeling; optic nerve grading; microglial morphology

   PMID:26544197

   Open questions at the time

   • Whether C1q acts via opsonization or membrane attack complex not distinguished
   • Downstream effectors on microglia not identified
6. 2017 High

   Cell-type-specific deletion proved microglia are the sole source of brain C1q, resolving whether peripheral or neuronal sources contribute.

   Evidence Conditional C1qa knockout in microglia (Cx3cr1-CreERT2); immunohistochemistry, qPCR, and western blot across tissues

   PMID:28264694

   Open questions at the time

   • Signals that induce microglial C1qa upregulation in disease not defined
   • Whether astrocytes can produce C1q under extreme conditions not excluded
7. 2021 High

   C1qa knockout mice showed dramatically increased viral loads and pathology upon coronavirus infection, establishing that classical complement pathway initiation via C1q is essential for antiviral defense in vivo.

   Evidence CRISPR-generated C1qa KO mice infected with MHV-A59; viral titers, histopathology, and cytokine profiling

   PMID:34056877

   Open questions at the time

   • Whether protection is via opsonization, neutralization, or downstream C3b deposition not dissected
   • Applicability to human coronaviruses not tested
8. 2023 High

   A post-transcriptional regulatory axis was uncovered: METTL3-mediated m6A modification of C1QA mRNA, read by YTHDF2, suppresses C1QA expression and confers rituximab resistance in lymphoma cells by reducing complement-dependent cytotoxicity.

   Evidence RIP-qPCR and RNA pulldown identifying METTL3/YTHDF2 on C1QA mRNA; knockdown/overexpression rescue of rituximab sensitivity in vitro and in vivo

   PMID:37907575

   Open questions at the time

   • Specific m6A site(s) on C1QA mRNA not mapped
   • Whether this regulatory axis operates in macrophages or other C1q-producing cells unknown
9. 2024 Medium

   Multiple studies extended C1qa's roles in neural injury and disease: C1qa mediates microglial synaptic pruning correlated with Alzheimer's pathology, exerts context-dependent effects in intracerebral hemorrhage, and participates in a pro-tumor feedback loop with NLRP12 in tumor-associated macrophages.

   Evidence FAD4T AD mouse model with electrophysiology and spine density (PMID:38266812); C1qa KO in ICH and thrombin injection models with MRI/IHC (PMID:39370487); NLRP12 KO and OE with tumor growth and T cell assays (PMID:39527158)

   PMID:38266812 PMID:39370487 PMID:39527158

   Open questions at the time

   • Synaptic pruning link in AD is correlative without C1qa KO rescue in the same study
   • Bidirectional ICH phenotype mechanisms not resolved
   • Direct C1qA–NLRP12 physical interaction not demonstrated

• Key unresolved questions include the structural basis of C1qA interactions with diverse ligands, the signals that regulate microglial C1qa transcription in health and disease, and whether intracellular C1qA-RIG-I signaling operates at physiological expression levels.
• No high-resolution structure of full-length C1q or C1qA–ligand complexes
• Transcriptional regulation of C1qa in microglia largely uncharacterized
• Intracellular RIG-I-enhancing function awaits independent replication and endogenous-level validation